CART-19 T Cell in CD19 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)
Clinical trial NCT03896854 · UNKNOWN
Trial details
- NCT number
- NCT03896854
- Sponsor
- Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-18
- Primary completion
- 2024-12-31
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.